BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27178966)

  • 1. A Comprehensive Approach to the Management of Children and Adults with Chronic Granulomatous Disease.
    Thomsen IP; Smith MA; Holland SM; Creech CB
    J Allergy Clin Immunol Pract; 2016; 4(6):1082-1088. PubMed ID: 27178966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Infectious Complications in Patients With Chronic Granulomatous Disease.
    Slack MA; Thomsen IP
    J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S25-S30. PubMed ID: 29746681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Infections and Target Organs Associated with Chronic Granulomatous Disease in Iran.
    Mortaz E; Azempour E; Mansouri D; Tabarsi P; Ghazi M; Koenderman L; Roos D; Adcock IM
    Int Arch Allergy Immunol; 2019; 179(1):62-73. PubMed ID: 30904913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.
    Ben-Ari J; Wolach O; Gavrieli R; Wolach B
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):881-94. PubMed ID: 23030328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic granulomatous disease: Single-center Spanish experience.
    Robles-Marhuenda A; Álvarez-Troncoso J; Rodríguez-Pena R; Busca-Arenzana C; López-Granados E; Arnalich-Fernández F
    Clin Immunol; 2020 Feb; 211():108323. PubMed ID: 31830531
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France.
    Dunogué B; Pilmis B; Mahlaoui N; Elie C; Coignard-Biehler H; Amazzough K; Noël N; Salvator H; Catherinot E; Couderc LJ; Sokol H; Lanternier F; Fouyssac F; Bardet J; Bustamante J; Gougerot-Pocidalo MA; Barlogis V; Masseau A; Durieu I; Lecuit M; Suarez F; Fischer A; Blanche S; Hermine O; Lortholary O
    Clin Infect Dis; 2017 Mar; 64(6):767-775. PubMed ID: 28362954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterial disease in patients with chronic granulomatous disease: A retrospective analysis of 71 cases.
    Conti F; Lugo-Reyes SO; Blancas Galicia L; He J; Aksu G; Borges de Oliveira E; Deswarte C; Hubeau M; Karaca N; de Suremain M; Guérin A; Baba LA; Prando C; Guerrero GG; Emiroglu M; Öz FN; Yamazaki Nakashimada MA; Gonzalez Serrano E; Espinosa S; Barlan I; Pérez N; Regairaz L; Guidos Morales HE; Bezrodnik L; Di Giovanni D; Dbaibo G; Ailal F; Galicchio M; Oleastro M; Chemli J; Danielian S; Perez L; Ortega MC; Soto Lavin S; Hertecant J; Anal O; Kechout N; Al-Idrissi E; ElGhazali G; Bondarenko A; Chernyshova L; Ciznar P; Herbigneaux RM; Diabate A; Ndaga S; Konte B; Czarna A; Migaud M; Pedraza-Sánchez S; Zaidi MB; Vogt G; Blanche S; Benmustapha I; Mansouri D; Abel L; Boisson-Dupuis S; Mahlaoui N; Bousfiha AA; Picard C; Barbouche R; Al-Muhsen S; Espinosa-Rosales FJ; Kütükçüler N; Condino-Neto A; Casanova JL; Bustamante J
    J Allergy Clin Immunol; 2016 Jul; 138(1):241-248.e3. PubMed ID: 26936803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penetration and intracellular bioactivity of antibiotics. Role in the treatment of infections in children with chronic granulomatous disease].
    D'Elia R
    G Ital Chemioter; 1985; 32(2):505-10. PubMed ID: 3833595
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients.
    Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Berger-Achituv S; Stauber T; Ben Ari J; Rottem M; Schlesinger Y; Grisaru-Soen G; Abuzaitoun O; Marcus N; Zion Garty B; Broides A; Levy J; Stepansky P; Etzioni A; Somech R; Roos D
    Am J Hematol; 2017 Jan; 92(1):28-36. PubMed ID: 27701760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary manifestations in adult patients with chronic granulomatous disease.
    Salvator H; Mahlaoui N; Catherinot E; Rivaud E; Pilmis B; Borie R; Crestani B; Tcherakian C; Suarez F; Dunogue B; Gougerot-Pocidalo MA; Hurtado-Nedelec M; Dreyfus JF; Durieu I; Fouyssac F; Hermine O; Lortholary O; Fischer A; Couderc LJ
    Eur Respir J; 2015 Jun; 45(6):1613-23. PubMed ID: 25614174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical features and genetic mutations of chronic granulomatous disease: results from a reference centre at middle Anatolia.
    Patiroglu T; Gungor HE; Unal E; Koker Y
    Genet Couns; 2013; 24(3):327-35. PubMed ID: 24341149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations in the Diagnosis of Chronic Granulomatous Disease.
    Yu JE; Azar AE; Chong HJ; Jongco AM; Prince BT
    J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S6-S11. PubMed ID: 29746674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease.
    Magnani A; Brosselin P; Beauté J; de Vergnes N; Mouy R; Debré M; Suarez F; Hermine O; Lortholary O; Blanche S; Fischer A; Mahlaoui N
    J Allergy Clin Immunol; 2014 Sep; 134(3):655-662.e8. PubMed ID: 24985400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive fungal infections in patients with chronic granulomatous disease.
    Henriet S; Verweij PE; Holland SM; Warris A
    Adv Exp Med Biol; 2013; 764():27-55. PubMed ID: 23654055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic granulomatous disease--not only the lack of oxygen radicals].
    Palmblad J; Gyllenhammar H; Bratt J; Ahlin A
    Lakartidningen; 2005 Apr 4-10; 102(14):1036-8, 1041. PubMed ID: 15892472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary pulmonary botryomycosis. A manifestation of chronic granulomatous disease.
    Paz HL; Little BJ; Ball WC; Winkelstein JA
    Chest; 1992 Apr; 101(4):1160-2. PubMed ID: 1555442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.
    Henrickson SE; Jongco AM; Thomsen KF; Garabedian EK; Thomsen IP
    J Pediatric Infect Dis Soc; 2018 May; 7(suppl_1):S18-S24. PubMed ID: 29746679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the diagnosis and treatment of chronic granulomatous disease.
    Seger RA
    Curr Opin Hematol; 2011 Jan; 18(1):36-41. PubMed ID: 21076296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease.
    Margolis DM; Melnick DA; Alling DW; Gallin JI
    J Infect Dis; 1990 Sep; 162(3):723-6. PubMed ID: 2117627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.